|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 39/00 | |
| C12P 21/08 | |||
| C07K 16/22 | |||
| C07K 16/28 | |||
| C07K 16/30 |
| (11) | Number of the document | 2467156 |
| (13) | Kind of document | T |
| (96) | European patent application number | 10810448.0 |
| Date of filing the European patent application | 2010-08-16 | |
| (97) | Date of publication of the European application | 2012-06-27 |
| (45) | Date of publication and mention of the grant of the patent | 2017-11-01 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2010/045651 |
| Date | 2010-08-16 |
| (87) | Number | WO 2011/022339 |
| Date | 2011-02-24 |
| (30) | Number | Date | Country code |
| 234574 P | 2009-08-17 | US |
| (72) |
THEUER, Charles, P., US
SEON, Ben K., US
|
| (73) |
Health Research, Inc.,
Elm and Carlton Streets, Buffalo, NY 14263,
US
Tracon Pharmaceuticals, Inc., 4350 La Jolla Village Drive Suite 800, San Diego, CA 92122, US |
| (54) | COMBINATION THERAPY OF CANCER WITH ANTI-ENDOGLIN ANTIBODIES AND ANTI-VEGF AGENTS |
| COMBINATION THERAPY OF CANCER WITH ANTI-ENDOGLIN ANTIBODIES AND ANTI-VEGF AGENTS |